Investment Thesis
Fortrea is a fundamentally distressed company with negative profitability across all metrics, negative operating and free cash flows, and deteriorating earnings. Combined with a current ratio of 0.95x and 1.98x debt-to-equity leverage, the company faces critical solvency and liquidity risks that are unsustainable absent dramatic operational turnaround.
Strengths
- Maintains $636.5M revenue base in essential medical laboratory services sector with structural demand
- Cash reserves of $147.5M provide near-term operational runway and refinancing buffer
- Presence of 11 insider Form 4 filings suggests some management activity and engagement
Risks
- Negative operating cash flow (-$17.0M) and free cash flow (-$25.0M) indicate ongoing economic value destruction with ~6 year cash burn runway at current rates
- Current ratio of 0.95x reveals acute liquidity stress with liabilities exceeding current assets, indicating potential near-term solvency crisis
- Operating income of -$3.4M with negative interest coverage means debt service is entirely unsustainable from operations; company is technically insolvent on cash basis
- Earnings deteriorating rapidly with -194.6% EPS decline YoY while net margin is -3.7%, with minimal 1.0% YoY revenue growth providing no operational offset
- High leverage of 1.98x debt-to-equity combined with $1.0B long-term debt creates refinancing risk if liquidity deteriorates further
- Negative ROE (-4.5%) and ROA (-0.9%) demonstrate severe capital inefficiency and shareholder value destruction
Key Metrics to Watch
- Operating cash flow trajectory and path to positive cash generation from operations
- Current ratio and overall working capital position - critical leading indicator of solvency
- Interest coverage ratio improvement and debt refinancing capability at maturity
- Revenue growth acceleration and operating margin expansion toward sustainability
- Management's capital allocation decisions regarding debt reduction versus operational reinvestment
Financial Metrics
Revenue
636.5M
Net Income
-23.6M
EPS (Diluted)
$-0.25
Free Cash Flow
-25.0M
Total Assets
2.7B
Cash
147.5M
Profitability Ratios
Gross Margin
N/A
Operating Margin
-0.5%
Net Margin
-3.7%
ROE
-4.5%
ROA
-0.9%
FCF Margin
-3.9%
Balance Sheet & Liquidity
Current Ratio
0.95x
Quick Ratio
0.95x
Debt/Equity
1.98x
Debt/Assets
80.4%
Interest Coverage
-0.05x
Long-term Debt
1.0B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-07T09:00:00.231150 |
Data as of: 2026-03-31 |
Powered by Claude AI